AL | Mortality | ||||
---|---|---|---|---|---|
OR | 95% CI | OR | 95% CI | ||
Case-mix factors | |||||
Age | 0.99 | 0.98 to 1.02 | 2.65 | 2.33 to 3.04 | |
Gender | Male | 1.31 | 1.11 to 1.55 | 1.82 | 1.39 to 2.37 |
ASA | 2 | 1.01 | 0.84 to 1.22 | 3.09 | 1.54 to 6.17 |
3+ | 1.00 | 0.80 to 1.24 | 6.44 | 3.46 to 13.12 | |
BMI | 0.91 | 0.74 to 1.13 | 0.99 | 0.97 to 1.02 | |
Two or more comorbidities | 0.88 | 0.70 to 1.10 | 1.17 | 0.82 to 1.67 | |
Cardiovascular disease | 0.85 | 0.70 to 1.04 | 1.21 | 0.90 to 1.62 | |
Pulmonary disease | 0.92 | 0.71 to 1.20 | 1.44 | 1.06 to 1.97 | |
Diabetes | 0.99 | 0.77 to 1.28 | 1.12 | 0.81 to 1.55 | |
Crohn's disease | 1.06 | 0.43 to 2.60 | 1.35 | 0.36 to 4.98 | |
Preoperative blood loss | 0.72 | 0.42 to 1.25 | 0.68 | 0.23 to 2.00 | |
Steroid treatment | 1.27 | 0.81 to 2.00 | 1.25 | 0.72 to 2.15 | |
Renal disease | 1.34 | 1.01 to 1.78 | 0.91 | 0.62 to 1.34 | |
Abdominal surgical history | 1.03 | 0.87 to 1.22 | 0.87 | 0.67 to 1.14 | |
T stage | T3 | 1.03 | 0.87 to 1.21 | 1.05 | 0.81 to 1.36 |
T4 | 1.13 | 0.78 to 1.64 | 1.22 | 0.71 to 2.10 | |
Additional resection | 1.20 | 0.88 to 1.64 | 0.96 | 0.59 to 1.55 | |
Urgent resection | 1.32 | 1.01 to 1.73 | 2.18 | 1.60 to 2.98 | |
Tumour location | Transverse colon | 1.93 | 1.49 to 2.50 | 1.25 | 0.89 to 1.76 |
Sigmoid | 1.68 | 1.33 to 2.11 | 0.70 | 0.50 to 1.00 | |
Rectum | 2.22 | 1.49 to 3.29 | 1.04 | 0.52 to 2.04 | |
Treatment factors | |||||
Neoadjuvant therapy | 5×5 | 1.70 | 1.13 to 2.54 | 0.88 | 0.42 to 1.85 |
Chemoradiotherapy | 1.33 | 0.84 to 2.09 | 0.30 | 0.09 to 0.98 | |
Defunctioning stoma | 0.54 | 0.42 to 0.70 | 1.15 | 0.69 to 1.89 | |
Transfusion | 4.27 | 3.56 to 5.12 | 4.06 | 3.14 to 5.25 |
Age and BMI were analysed as continuous variables.
Bold numbers are significant ORs (p<0.05).
AL, anastomotic leakage; ASA, American Society of Anesthesiologists score; BMI, body mass index.